125 related articles for article (PubMed ID: 9678077)
1. Oral contraceptives and bone metabolism.
Volpe A; Malmusi S; Zanni AL; Landi S; Cagnacci A
Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):225-8. PubMed ID: 9678077
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral contraceptives on bone mineral density.
Gambacciani M; Monteleone P; Ciaponi M; Sacco A; Genazzani AR
Treat Endocrinol; 2004; 3(3):191-6. PubMed ID: 16026114
[TBL] [Abstract][Full Text] [Related]
3. Bone loss, contraception and lactation.
Mehta S
Acta Obstet Gynecol Scand; 1993 Apr; 72(3):148-56. PubMed ID: 8385847
[TBL] [Abstract][Full Text] [Related]
4. Changes in bone turnover following gonadotropin-releasing hormone (GnRH) agonist administration and estrogen treatment in cynomolgus monkeys: a short-term model for evaluation of antiresorptive therapy.
Stroup GB; Hoffman SJ; Vasko-Moser JA; Lechowska BA; Jenkins EL; Dare LC; Gowen M
Bone; 2001 May; 28(5):532-7. PubMed ID: 11344053
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
[TBL] [Abstract][Full Text] [Related]
6. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
[TBL] [Abstract][Full Text] [Related]
7. Bone-sparing properties of oral contraceptives.
DeCherney A
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.
Castelo-Branco C; MartÃnez de Osaba MJ; Pons F; Fortuny A
Metabolism; 1997 Apr; 46(4):437-40. PubMed ID: 9109850
[TBL] [Abstract][Full Text] [Related]
9. [Low-dose oral contraception and bone density].
Karck U; Breckwoldt M
Ther Umsch; 2001 Sep; 58(9):547-51. PubMed ID: 11594153
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
Gambacciani M; Ciaponi M; Cappagli B; Benussi C; Genazzani AR
Osteoporos Int; 2000; 11(6):544-8. PubMed ID: 10982172
[TBL] [Abstract][Full Text] [Related]
11. Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone.
Bell KL; Loveridge N; Lindsay PC; Lunt M; Garrahan N; Compston JE; Reeve J
J Bone Miner Res; 1997 Aug; 12(8):1231-40. PubMed ID: 9258753
[TBL] [Abstract][Full Text] [Related]
12. [The effect of oral contraceptives on bone density in climacteric females].
Enzelsberger H; Metka M; Heytmanek G; Huber J
Zentralbl Gynakol; 1989; 111(14):967-73. PubMed ID: 2508368
[TBL] [Abstract][Full Text] [Related]
13. Overview of bone mineral density in postmenopausal women.
Notelovitz M
J Reprod Med; 2002 Jan; 47(1 Suppl):71-81. PubMed ID: 11829080
[TBL] [Abstract][Full Text] [Related]
14. Difference in bone acquisition among hormonally treated postmenopausal women with normal and low bone mass.
Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom K
J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S586-92. PubMed ID: 11853286
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
Gambacciani M; Spinetti A; Taponeco F; Cappagli B; Piaggesi L; Fioretti P
Obstet Gynecol; 1994 Mar; 83(3):392-6. PubMed ID: 8127531
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and bone mineral density: A population-based study.
Pasco JA; Kotowicz MA; Henry MJ; Panahi S; Seeman E; Nicholson GC
Am J Obstet Gynecol; 2000 Feb; 182(2):265-9. PubMed ID: 10694322
[TBL] [Abstract][Full Text] [Related]
19. Biochemical aspects of hormonal contraception: effects on bone metabolism.
Volpe A; Amram A; Cagnacci A; Battaglia C
Eur J Contracept Reprod Health Care; 1997 Jun; 2(2):123-6. PubMed ID: 9678101
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
Taechakraichana N; Limpaphayom K; Ninlagarn T; Panyakhamlerd K; Chaikittisilpa S; Dusitsin N
Obstet Gynecol; 2000 Jan; 95(1):87-94. PubMed ID: 10636509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
